NEW YORK, NY--(Marketwire - November 14, 2007) - Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced third quarter earnings for 2007. For the quarter ended September 30, 2007 total operating revenues decreased by 16.8% to $349,547 from $420,140 for the same period in 2006. The major reason for the decrease in operating revenues was that no instruments were sold during the current quarter and one Blood Volume Analyzer was sold during the quarter ended September 30, 2006. For the quarter ended September 30, 2007 costs and expenses increased by 15.3% to $ 1,918,386 from $ 1,663,524 in 2006.
